Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Elevance Health's Enterprise Value is €99,293 Mil.
Elevance Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was €6,578 Mil. Therefore, Elevance Health's EV-to-EBIT ratio for today is 15.10.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Elevance Health's Enterprise Value is €99,293 Mil.
Elevance Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was €7,890 Mil. Therefore, Elevance Health's EV-to-EBITDA ratio for today is 12.58.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Elevance Health's Enterprise Value is €99,293 Mil.
Elevance Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was €172,252 Mil. Therefore, Elevance Health's EV-to-Revenue ratio for today is 0.58.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Elevance Health's Enterprise Value is €99,293 Mil.
Elevance Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €5,575 Mil. Therefore, Elevance Health's EV-to-FCF ratio for today is 17.81.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Elevance Health (WBO:ELV) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Elevance Health's current Enterprise Value is €99,293 Mil.
Elevance Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €6,578 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Elevance Health's current Enterprise Value is €99,293 Mil.
Elevance Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €7,890 Mil.
Elevance Health's current Enterprise Value is €99,293 Mil.
Elevance Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €172,252 Mil.
Elevance Health's current Enterprise Value is €99,293 Mil.
Elevance Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €6,567 Mil.
Elevance Health's current Enterprise Value is €99,293 Mil.
Elevance Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €5,575 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elevance Health Enterprise Value Related Terms
Elevance Health Enterprise Value Historical Data
* Premium members only.
The historical data trend for Elevance Health's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:ELV vs CI, HUM, CVS: Enterprise Value Comparison
For the Healthcare Plans subindustry, Elevance Health's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elevance Health Enterprise Value vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Elevance Health's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Elevance Health's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Elevance Health's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elevance Health (WBO:ELV) has a Enterprise Value of €99,293 Mil as of Jul. 03, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Elevance Health and its competitors.
Is Elevance Health's Enterprise Value too high?
Elevance Health's current Enterprise Value is €99,293 Mil. Overall, Elevance Health has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's Enterprise Value compare to CI and HUM?
Elevance Health's Enterprise Value of €99,293 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Plans company?
A good Enterprise Value depends on the Healthcare Plans industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Elevance Health and its competitors. Elevance Health's current Enterprise Value is €99,293 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (WBO:ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is €446.79, compared to a current price of €367.40 — trading 17.8% below its estimated fair value. The current Enterprise Value is €99,293 Mil. Elevance Health's overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Elevance Health (WBO:ELV), the current Enterprise Value is €99,293 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elevance Health (WBO:ELV) Overvalued in 2026?
Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued.
The current stock price of €367.40 is trading 17.8% below its estimated GF Value™ of €446.79.
GuruFocus considers Elevance Health to be Modestly Undervalued.
Key valuation signals for WBO:ELV:
Enterprise Value: €99,293 Mil
GF Value™: €446.79 vs. price of €367.40 (17.8% below fair value)
No single metric tells the full story. See the WBO:ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
82GF Score
Get the complete analysis for WBO:ELV
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:ELV has been successfully added to your 
